Sirion To Submit NDA For Ocular Antiviral Gel Virgan In Fourth Quarter
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm licenses the compound from France-based Laboratoires Théa, marketer of the herpes simplex keratitis treatment in Europe.